HK1028046A1 - Intermediates and methods useful in the semisynthesis of paclitaxel and analogs - Google Patents

Intermediates and methods useful in the semisynthesis of paclitaxel and analogs

Info

Publication number
HK1028046A1
HK1028046A1 HK00107527A HK00107527A HK1028046A1 HK 1028046 A1 HK1028046 A1 HK 1028046A1 HK 00107527 A HK00107527 A HK 00107527A HK 00107527 A HK00107527 A HK 00107527A HK 1028046 A1 HK1028046 A1 HK 1028046A1
Authority
HK
Hong Kong
Prior art keywords
semisynthesis
paclitaxel
analogs
intermediates
methods useful
Prior art date
Application number
HK00107527A
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK1028046A1 publication Critical patent/HK1028046A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HK00107527A 1997-11-21 2000-11-24 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs HK1028046A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/975,804 US5917062A (en) 1997-11-21 1997-11-21 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
PCT/IB1998/001912 WO1999026939A1 (en) 1997-11-21 1998-11-19 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs

Publications (1)

Publication Number Publication Date
HK1028046A1 true HK1028046A1 (en) 2001-02-02

Family

ID=25523419

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00107527A HK1028046A1 (en) 1997-11-21 2000-11-24 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs

Country Status (20)

Country Link
US (2) US5917062A (cs)
EP (1) EP1049686B9 (cs)
JP (1) JP3445973B2 (cs)
KR (1) KR100545436B1 (cs)
CN (1) CN1229364C (cs)
AT (1) ATE308533T1 (cs)
AU (1) AU746448C (cs)
CA (1) CA2310778C (cs)
CZ (1) CZ296350B6 (cs)
DE (1) DE69832202T2 (cs)
DK (1) DK1049686T3 (cs)
ES (1) ES2251106T3 (cs)
HK (1) HK1028046A1 (cs)
HU (1) HUP0100375A3 (cs)
NO (1) NO20002600L (cs)
PL (1) PL192422B1 (cs)
RU (1) RU2213739C2 (cs)
SI (1) SI1049686T1 (cs)
SK (1) SK285797B6 (cs)
WO (1) WO1999026939A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19925926A1 (de) * 1999-06-08 2000-12-14 Bayer Ag Katalysatoren auf Basis Titan-haltiger, organisch-anorganischer Hybridmaterialien zur selektiven Oxidation von Kohlenwasserstoffen
JP4502338B2 (ja) * 1999-09-17 2010-07-14 株式会社横浜国際バイオ研究所 タキソイド化合物の製造法
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
IT1319682B1 (it) 2000-12-06 2003-10-23 Indena Spa Procedimento di sintesi del paclitaxel.
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20020782A1 (it) * 2002-04-12 2003-10-13 Indena Spa Processo semisintetico per la preparazione di n-debenzoilpaclitaxel
NZ576355A (en) * 2006-10-20 2012-04-27 Scinopharm Singapore Pte Ltd Process for making crystalline anhydrous docetaxel
EP2358693A4 (en) * 2008-11-20 2012-04-18 Reddys Lab Ltd Dr PREPARATION OF DOCETAXEL
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34277A (en) * 1862-01-28 Improvement in lamps
FR2601676B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
USRE34277E (en) * 1988-04-06 1993-06-08 Centre National De La Recherche Scientifique Process for preparing taxol
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
MY110249A (en) * 1989-05-31 1998-03-31 Univ Florida State Method for preparation of taxol using beta lactam
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
CA2071160A1 (en) * 1991-07-31 1993-02-01 Vittorio Farina Asymmetric synthesis of taxol side chain
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5470866A (en) * 1992-08-18 1995-11-28 Virginia Polytechnic Institute And State University Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
US5703247A (en) * 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
CA2170661A1 (en) * 1995-03-22 1996-09-23 John K. Thottathil Novel methods for the preparation of taxanes using oaxzolidine intermediates
IT1275435B (it) * 1995-05-19 1997-08-07 Indena Spa Derivati della 10-desacetil-14beta-idrossibaccatina iii,loro metodo di preparazione e formulazioni che li contengono
KR100225535B1 (ko) * 1996-08-27 1999-10-15 정지석 파클리탁셀의 제조방법

Also Published As

Publication number Publication date
PL192422B1 (pl) 2006-10-31
AU746448C (en) 2002-12-05
CZ296350B6 (cs) 2006-02-15
AU1170599A (en) 1999-06-15
ES2251106T3 (es) 2006-04-16
DK1049686T3 (da) 2006-01-16
NO20002600L (no) 2000-07-17
EP1049686A1 (en) 2000-11-08
CZ20001869A3 (cs) 2000-11-15
NO20002600D0 (no) 2000-05-19
WO1999026939A1 (en) 1999-06-03
AU746448B2 (en) 2002-05-02
KR20010024619A (ko) 2001-03-26
DE69832202T2 (de) 2006-07-13
PL340553A1 (en) 2001-02-12
SI1049686T1 (sl) 2006-02-28
DE69832202D1 (de) 2005-12-08
HUP0100375A2 (hu) 2001-12-28
HUP0100375A3 (en) 2002-04-29
JP2001524476A (ja) 2001-12-04
US5907042A (en) 1999-05-25
CA2310778C (en) 2005-02-22
US5917062A (en) 1999-06-29
CA2310778A1 (en) 1999-06-03
CN1279677A (zh) 2001-01-10
CN1229364C (zh) 2005-11-30
JP3445973B2 (ja) 2003-09-16
KR100545436B1 (ko) 2006-01-24
EP1049686B1 (en) 2005-11-02
ATE308533T1 (de) 2005-11-15
RU2213739C2 (ru) 2003-10-10
SK285797B6 (sk) 2007-08-02
SK7322000A3 (en) 2000-11-07
EP1049686B9 (en) 2005-12-28

Similar Documents

Publication Publication Date Title
EP0731106A4 (en) NEW PEPTIDE DERIVATIVES
FI945703A0 (fi) 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus
HUT56558A (en) Process for producing oxetanones
EP0762879A4 (en) STEREOCHEMICAL WORDMAN DERIVATIVES
WO2001057014A3 (en) Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
HK1028046A1 (en) Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
EA200100347A1 (ru) Метод и композиция для лечения и профилактики туберкулеза
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
BG105766A (en) New process for preparing pesticidal intermediates
BG96682A (bg) Метод за получаване на циклохексанови и тетрахидропиранови производни
IN187760B (cs)
BG106002A (en) Process for preparing pesticidal intermediates
AU2001235668A1 (en) Xanthine derivatives, intermediates and use for treating osteoporosis
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
BG104073A (en) Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
DE69703115D1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
PL320912A1 (en) Novel derivatives of coumarin and method of obtaining them
PL312212A1 (en) Method of obtaining oxazolydinocarboxylic acid suitable for use in production of taxoides exhibiting therapeutic properties
AU1381597A (en) Method for selective protection of baccatin derivatives and its application to taxane synthesis
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
IL141304A0 (en) A method for the preparation of c-4 deacetyltaxane derivatives and the enzyme for use therein
AU4132199A (en) Method for producing 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol and intermediate products obtained by said method

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091119